These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 32116658)

  • 1. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities.
    Danks L; Semete-Makokotlela B; Otwombe K; Parag Y; Walker S; Salek S
    Front Med (Lausanne); 2023; 10():1265058. PubMed ID: 37937144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment.
    Sithole T; Ngum N; Owusu-Asante M; Walker S; Salek S
    Int J Health Policy Manag; 2024; 13():8070. PubMed ID: 39099506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
    Sithole T; Mahlangu G; Walker S; Salek S
    Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Evaluation of the Swissmedic Regulatory Framework for New Active Substances.
    Bujar M; Dalla Torre di Sanguinetto SA; Kermad A; Bolte C; McAuslane N
    Ther Innov Regul Sci; 2024 Jan; 58(1):153-165. PubMed ID: 37884784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Mixed Methods Study to Explore Relevant Metrics for a Results Framework Measuring the Public Health Impact of Reliance-Based Pathways.
    Adams I; Cuff PA; Liberti L
    Ther Innov Regul Sci; 2023 Nov; 57(6):1260-1268. PubMed ID: 37552399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Women in science - regulatory science 2023.
    Thomsen MDT; Knudsen LE
    Front Med (Lausanne); 2024; 11():1389438. PubMed ID: 38523912
    [No Abstract]   [Full Text] [Related]  

  • 9. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
    Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
    Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The harmonization of the regulation of blood products: a European perspective.
    Seitz R; Heiden M; Nübling CM; Unger G; Löwer J
    Vox Sang; 2008 May; 94(4):267-76. PubMed ID: 18179678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
    Koyuncu O; Gursoz H; Alkan A; Cetintas HC; Pasaoglu T; Mashaki Ceyhan E; Walker S
    Front Pharmacol; 2019; 10():1557. PubMed ID: 32116658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore.
    Mashaki Ceyhan E; Gürsöz H; Alkan A; Coşkun H; Koyuncu O; Walker S
    Front Pharmacol; 2018; 9():9. PubMed ID: 29422861
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities.
    Sithole T; Mahlangu G; Salek S; Walker S
    Ther Innov Regul Sci; 2021 May; 55(3):474-489. PubMed ID: 33387356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
    Keyter A; Salek S; Gouws J; Banoo S; Walker S
    Ther Innov Regul Sci; 2020 Jul; 54(4):878-887. PubMed ID: 32557310
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.